Emtricitabine (FTC), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse transcriptase inhibitor (NRTI) for the treatment of HIV infection in adults and children.
Emtricitabine is also marketed in a fixed-dose combination with tenofovir (Viread) under the brand name Truvada.
A fixed-dose triple combination of emtricitabine, tenofovir and efavirenz (Sustiva, marketed
|Packaging Type||30 Tablets|
|Dose/Strength (ex. 1 mg or 1 ml)||Emtricitabine(200 Mg),Tenofovir(300 Mg)|